More about Anupam Rasayan India Ltd
Fundamentals for Anupam Rasayan India Ltd
Regulatory Filings for Anupam Rasayan India Ltd
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Anupam Rasayan India Ltd
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
ANURAS's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 61.218536 |
| debtToEquity | 37.505000 |
| earningsGrowth | 0.677000 |
| revenueGrowth | 0.313000 |
| grossMargins | 0.441230 |
| operatingMargins | 0.181500 |
| trailingEps | 15.450000 |
| forwardEps | 21.928000 |
ANURAS's forward PE ratio being too high suggests the stock's future gains could be limited, with a potential for price correction. It's critical to weigh this alongside other key fundamental parameters for a comprehensive assessment.
Anupam Rasayan India Ltd's positive earnings and revenue growth suggest that the company is poised for business expansion. This financial strength indicates that Anupam Rasayan India Ltd is expected to continue growing, with rising profits and sales contributing to its long-term success.
Anupam Rasayan India Ltd's forward EPS is greater than its trailing EPS, indicating that the company is expected to deliver higher profitability this year. This suggests that Anupam Rasayan India Ltd is projected to improve its earnings, reflecting positive growth compared to last year's financial performance.
Price projections:
The price of ANURAS has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.
Recommendation changes over time:
Recent analysis shows a strong buy bias for ANURAS, encouraging investors to view it as a solid investment option. The positive sentiment surrounding ANURAS suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy